BIFIDO Co., Ltd.

Research BIFIDO Co., Ltd. (238200.KQ) on Bullrun: market cap KRW 21.19B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 21.19B.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 21.19Bn/an/an/a

Dividend history

About BIFIDO Co., Ltd.

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.

Related stock research

South Korea stocks South Korea Consumer Defensive stocks A-Z stock index

Other Consumer Defensive stocks

Daehan Flour Mills Co.,Ltd (001130.KS) Daesang Corporation (001680.KS) Korea Industrial Co., Ltd. (002140.KS) Choheung Corporation (002600.KS) Samyang Foods Co., Ltd. (003230.KS) Daejoo Inc. (003310.KQ) Harim Holdings Co., Ltd. (003380.KQ) Hansung Enterprise Co.,Ltd (003680.KS) Namyang Dairy Products Co., Ltd (003920.KS) Sajodaerim Corporation (003960.KS) Nongshim Co., Ltd. (004370.KS) Seoul Food Industrial.Co.,Ltd (004410.KS)

Frequently asked questions

What is BIFIDO Co., Ltd.'s market cap?

BIFIDO Co., Ltd.'s market capitalization is KRW 21.19B.

What does BIFIDO Co., Ltd. do?

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.